Results 11 to 20 of about 24,661 (222)

Integrated Multi-Omics Reveals Cellular States and Microenvironmental Remodeling in Coexisting DCIS and IDC. [PDF]

Adv Sci (Weinh)
Coexisting DCIS and IDC samples are profiled using spatial transcriptomics, single‐cell RNA sequencing, and single‐cell DNA sequencing. Integrative multi‐omics analysis reveals distinct malignant epithelial and microenvironmental features between DCIS and IDC, which are further validated using Xenium and multiplex immunohistochemistry.
Zhang N, Wan T, Zhang S, Jiang Y, Su P, Liu J, Chen Z, Hao J, Wang H, Chen B, Zhao W, Wang L, Xing T, Zhang Q, Schmitz U, Ding Z, Crosetto N, Liu B, Yang Q.   +18 more
europepmc   +2 more sources

Interaction Design @ IDC Limerick [PDF]

Interaction Design and Architecture(s), 2005
Interaction Design @ IDC ...
Liam Bannon, Luigina Ciolfi
doaj   +3 more sources

IDC Herzliya

InDret, 2020
Pablo Salvador Coderch
doaj   +1 more source

Commentaries on IDC Theory in practice

Research and Practice in Technology Enhanced Learning, 2022
A total of seven scholars were invited to provide commentaries to the paper on the IDC experimental school in Taiwan. We collated their commentaries below, arranged in alphabetical order of the authors’ last names. We acknowledge and appreciate the excellent points raised by the commentators regarding the current and future ...
Wenli Chen 0004, Kampei Hayashi, Mas Nida Md. Khambari, Kinshuk, Jon Mason, Lung-Hsiang Wong, Kui Xie   +6 more
openaire   +2 more sources

Development of a Nomogram-Based Clinical Estimation Model for Pathological Upstaging in Patients With Preoperative Ductal Carcinoma In Situ. [PDF]

Kaohsiung J Med Sci
ABSTRACT Preoperative diagnosis of ductal carcinoma in situ (DCIS) may be followed by pathological upstaging to invasive ductal carcinoma (IDC) upon surgical excision, a discrepancy that significantly impacts surgical planning and decisions regarding sentinel lymph node biopsy (SLNB).
Chen YH, Li CL, Yang PF, Hsiao HH, Chen FM, Moi SH.   +5 more
europepmc   +2 more sources

Tracking CDK1 Dynamics With a Novel Biosensor Mouse and Clinical Cohorts to Predict CDK4/6 Inhibitor Sensitivity in ER+ Breast Cancer [PDF]

Advanced science
Cyclin‐dependent kinase (CDK) 1 activity is a dynamic marker of treatment response in estrogen receptor positive breast cancer. Patient cohorts reveal CDK1 activity increases during progression to invasive disease, where high expression correlates with poor survival. Using a novel Cdk1 biosensor mouse alongside in vitro models, we demonstrate that CDK1
Alexandrou S, Fernandez K, Huang M, Millar E, Vennin C, Eshraghi L, Lam T, Lee V, Brooks N, Stoehr J, Mendez C, Strathdee D, Stevenson D, Herrmann D, O'Toole S, Timpson P, Nobis M, Caldon C.   +17 more
europepmc   +2 more sources

Overexpression of TPL2 may be a predictor of good prognosis in patients with breast invasive ductal carcinoma

Scientific Reports, 2023
The objective of this study was to investigate the clinical significance and roles of tumor progression locus 2 (TPL2) and peptidyl-prolyl cis–trans isomerase 1 (Pin1) in the occurrence and development of breast invasive ductal carcinoma (IDC ...
Qin Yu, Dan Wan, Rong Fu, Feng Li, Yutao Zhang   +4 more
doaj   +1 more source

Evaluación de la respuesta patológica al tratamiento neoadyuvante en cáncer de recto. Experiencia del Instituto de Cancerología de Medellín (Colombia, 2011-2017)

Revista de Gastroenterología de México, 2021
Resumen: Introducción y objetivos: La terapia neoadyuvante en el cáncer de recto se asocia con una disminución del tamaño tumoral y es la indicación terapéutica para pacientes con tumores T3, T4 o con compromiso ganglionar.
L.J. Palacios-Fuenmayor, A.M. Naranjo-Isaza, C.A. Serna-Ortiz, D.A. Mosquera-Castro, L.M. Arbeláez-Leon, L.R. Gómez-Wolff, H.I. García-García, L.A. Sánchez-Patiño   +7 more
doaj   +1 more source

SARS-CoV-2 Spike Antibody Levels Trend among Sinopharm Vaccinated People

Iranian Journal of Public Health, 2021
None
Umar Saeed, Sara Rizwan Uppal, Zahra Zahid Piracha, Rizwan Uppal   +3 more
doaj   +1 more source

Evaluation of the pathologic response to neoadjuvant treatment in rectal cancer. Experience at the Instituto de Cancerología de Medellín (Colombia, 2011-2017)

Revista de Gastroenterología de México (English Edition), 2021
Introduction and aims: Neoadjuvant therapy in rectal cancer is associated with a decrease in tumor size and is the therapeutic indication for patients with T3 or T4 tumors or lymph node involvement.
L.J. Palacios-Fuenmayor, A.M. Naranjo-Isaza, C.A. Serna-Ortiz, D.A. Mosquera-Castro, L.M. Arbeláez-Leon, L.R. Gómez-Wolff, H.I. García-García, L.A. Sánchez-Patiño   +7 more
doaj   +1 more source